Heart regeneration

Nature

Volumn 473, Issue 7347, 2011, Pages 326-335

  Laflamme, Michael A ^a   Murry, Charles E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIBIAN; BACTERIAL DISEASE; CARDIOVASCULAR DISEASE; CYTOLOGY; DISEASE SPREAD; EXPERIMENTAL STUDY; FISH; MAMMAL;

ADULT STEM CELL; AMPHIBIA; BONE MARROW CELL; CARDIAC PROGENITOR CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); EMBRYO DEVELOPMENT; FIBROBLAST; FISH; GENE EXPRESSION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART REGENERATION; HUMAN; MONONUCLEAR CELL; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; STEM CELL; STEM CELL TRANSPLANTATION; STROMA CELL; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; HEART; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; NUCLEAR REPROGRAMMING; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

AMPHIBIA; MAMMALIA;

EID: 79956334658     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10147     Document Type: Review

References (100)

1. Carvalho, A. B. & de Carvalho, A. C. Heart regeneration: past, present and future. World J. Cardiol. 2, 107-111 (2010).
2. Rumyantsev, P. P. in Muscle Regeneration (ed. Mauro, A.) 335-355 (Raven, 1979).
3. Rumyantsev, P. P. Growth and Hyperplasia of Cardiac Muscle Cells (Harwood Academic, 1991).
4. Murry, C. E., Reinecke, H. & Pabon, L. M. Regeneration gaps: observations on stem cells and cardiac repair. J. Am. Coll. Cardiol. 47, 1777-1785 (2006).
5. Whelan, R. S., Kaplinskiy, V. & Kitsis, R. N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 72, 19-44 (2010).
6. Olivetti, G., Melissari, M., Capasso, J. M. & Anversa, P. Cardiomyopathy of the aging human heart. Circ. Res. 68, 1560-1568 (1991).
7. Laflamme, M. A., Zbinden, S., Epstein, S. E. & Murry, C. E. Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu. Rev. Pathol. 2, 307-339 (2007). (Pubitemid 46448068)
8. Povsic, T. J. & O'Connor, C. M. Cell therapy for heart failure: the need for a new therapeutic strategy. Expert Rev. Cardiovasc. Ther. 8, 1107-1126 (2010).
9. Oberpriller, J. O. & Oberpriller, J. C. Response of the adult newt ventricle to injury. J. Exp. Zool. 187, 249-253 (1974).
10. Poss, K. D., Wilson, L. G. & Keating, M. T. Heart regeneration in zebrafish. Science 298, 2188-2190 (2002). (Pubitemid 35471243)
11. Lepilina, A. et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 127, 607-619 (2006). (Pubitemid 44647426)
12. + cardiomyocytes. Nature 464, 601-605 (2010).
13. Jopling, C. et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464, 606-609 (2010).
14. Soonpaa, M. H. & Field, L. J. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ. Res. 83, 15-26 (1998). (Pubitemid 28322095)
15. Soonpaa, M. H. & Field, L. J. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am. J. Physiol. 272, H220-H226 (1997).
16. Hassink, R. J. et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc. Res. 78, 18-25 (2008). (Pubitemid 351430951)
17. Ahuja, P., Sdek, P. & MacLellan, W. R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87, 521-544 (2007). (Pubitemid 47086282)
18. Kuhn, B. et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nature Med. 13, 962-969 (2007). (Pubitemid 47222046)
19. Engel, F. B., Hsieh, P. C., Lee, R. T. & Keating, M. T. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl Acad. Sci. USA 103, 15546-15551 (2006). (Pubitemid 44625629)
20. Bersell, K., Arab, S., Haring, B. & Kuhn, B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138, 257-270 (2009).
21. Lorts, A., Schwanekamp, J. A., Elrod, J. W., Sargent, M. A. & Molkentin, J. D. Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair. Circ. Res. 104, e1-e7 (2009).
22. Hsieh, P. C. et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nature Med. 13, 970-974 (2007). (Pubitemid 47222045)
23. Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080 (2011).
24. Adler, C. P. Relationship between deoxyribonucleic acid content and nucleoli in human heart muscle cells and estimation of cell number during cardiac growth and hyperfunction. Recent Adv. Stud. Cardiac Struct. Metab. 8, 373-386 (1975).
25. Adler, C. P. & Friedburg, H. Myocardial DNA content, ploidy level and cell number in geriatric hearts: post-mortem examinations of human myocardium in old age. J. Mol. Cell Cardiol. 18, 39-53 (1986). (Pubitemid 16174714)
26. Li, F., Wang, X., Capasso, J. M. & Gerdes, A. M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell Cardiol. 28, 1737-1746 (1996). (Pubitemid 26300573)
27. Olivetti, G. et al. Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J. Mol. Cell Cardiol. 28, 1463-1477 (1996). (Pubitemid 26340901)
28. MacMahon, H. E. Hyperplasia and regeneration of the myocardium in infants and in children. Am. J. Pathol. 13, 845-854 (1937).
29. Beltrami, A. P. et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344, 1750-1757 (2001). (Pubitemid 32497029)
30. Rumyantsev, P. P. in Growth and Hyperplasia of Cardiac Muscle Cells (ed. Carlson, B. M.) 210-238 (Harwood Academic Publishers, 1991).
31. Adler, C. P. & Costabel, U. Cell number in human heart in atrophy, hypertrophy, and under the influence of cytostatics. Recent Adv. Stud. Cardiac Struct. Metab. 6, 343-355 (1975).
32. Herget, G. W., Neuburger, M., Plagwitz, R. & Adler, C. P. DNA content, ploidy level and number of nuclei in the human heart after myocardial infarction. Cardiovasc. Res. 36, 45-51 (1997). (Pubitemid 27463571)
33. Grajek, S. et al. Hypertrophy or hyperplasia in cardiac muscle. Eur. Heart J. 14, 40-47 (1993).
34. Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 (2009).
35. Kajstura, J. et al. Cardiomyogenesis in the adult human heart. Circ. Res. 107, 305-315 (2010).
36. Bergmann, O. et al. Identification of cardiomyocyte nuclei and assessment of ploidy for the analysis of cell turnover. Exp. Cell Res. 317, 188-194 (2010).
37. Kinsella, T. J. et al. A phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 10, 69-76 (1984). (Pubitemid 14160713)
38. Segers, V. F. & Lee, R. T. Stem-cell therapy for cardiac disease. Nature 451, 937-942 (2008). (Pubitemid 351301749)
39. Passier, R., van Laake, L. W. & Mummery, C. L. Stem-cell-based therapy and lessons from the heart. Nature 453, 322-329 (2008). (Pubitemid 351693138)
40. Smith, R. R. et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896-908 (2007). (Pubitemid 46294730)
41. Pfister, O. et al. Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circ. Res. 103, 825-835 (2008).
42. Tallini, Y. N. et al. c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc. Natl Acad. Sci. USA 106, 1808-1813 (2009).
43. Kubo, H. et al. Increased cardiac myocyte progenitors in failing human hearts. Circulation 118, 649-657 (2008).
44. Bearzi, C. et al. Human cardiac stem cells. Proc. Natl Acad. Sci. USA 104, 14068-14073 (2007). (Pubitemid 350003336)
45. Tang, X. L. et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121, 293-305 (2010).
46. +-expressing cells derived from neonatal and adult mouse hearts. Circulation 121, 1992-2000 (2010).
47. Patella, V. et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97, 971-978 (1998). (Pubitemid 28125469)
48. - cells found in the adult human heart represent a population of endothelial progenitor cells. Basic Res. Cardiol. 105, 545-556 (2010).
49. Messina, E. et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95, 911-921 (2004). (Pubitemid 39435006)
50. Chimenti, I. et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 106, 971-980 (2010).
51. Andersen, D. C., Andersen, P., Schneider, M., Jensen, H. B. & Sheikh, S. P. Murine 'cardiospheres' are not a source of stem cells with cardiomyogenic potential. Stem Cells 27, 1571-1581 (2009).
52. Orlic, D. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001). (Pubitemid 32290358)
53. Murry, C. E. et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664-668 (2004). (Pubitemid 38524810)
54. Balsam, L. B. et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668-673 (2004). (Pubitemid 38524811)
55. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J. & Kessler, P. D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98 (2002). (Pubitemid 34049148)
56. Mirotsou, M. et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl Acad. Sci. USA 104, 1643-1648 (2007). (Pubitemid 46214644)
57. Hatzistergos, K. E. et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ. Res. 107, 913-922 (2010).
58. Chen, S. L. et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94, 92-95 (2004).
59. Hare, J. M. et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277-2286 (2009).
60. Kehat, I. et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407-414 (2001). (Pubitemid 32730787)
61. Sartiani, L. et al. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25, 1136-1144 (2007). (Pubitemid 46684873)
62. He, J. Q., Ma, Y., Lee, Y., Thomson, J. A. & Kamp, T. J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 93, 32-39 (2003). (Pubitemid 36859038)
63. Zhu, W. Z., Santana, L. F. & Laflamme, M. A. Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS ONE 4, e5407 (2009).
64. Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30-e41 (2009).
65. Zwi, L. et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513-1523 (2009).
66. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998). (Pubitemid 28516247)
67. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007). (Pubitemid 350138099)
68. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
69. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
70. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
71. Shi, Y. et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568-574 (2008).
72. Nussbaum, J. et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21, 1345-1357 (2007). (Pubitemid 46684837)
73. Kehat, I. et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407-414 (2001). (Pubitemid 32730787)
74. Laflamme, M. A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnol. 25, 1015-1024 (2007). (Pubitemid 47517637)
75. + embryonic-stem-cell-derived population. Nature 453, 524-528 (2008). (Pubitemid 351733312)
76. Xu, X. Q. et al. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 76, 958-970 (2008).
77. Zhu, W. Z. et al. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ. Res. 107, 776-786 (2010).
78. Paige, S. L. et al. Endogenous Wnt/â-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS ONE 5, e11134 (2010).
79. Ueno, S. et al. Biphasic role for Wnt/â-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc. Natl Acad. Sci. USA 104, 9685-9690 (2007). (Pubitemid 47175327)
80. Bondue, A. et al. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 3, 69-84 (2008).
81. Wu, S. M. et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127, 1137-1150 (2006). (Pubitemid 44914005)
82. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151-1165 (2006). (Pubitemid 44895618)
83. Domian, I. J. et al. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 326, 426-429 (2009).
84. Caspi, O. et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50, 1884-1893 (2007). (Pubitemid 350007960)
85. Fernandes, S. et al. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J. Mol. Cell Cardiol. 49, 941-949 (2010).
86. van Laake, L. W., Passier, R., Doevendans, P. A. & Mummery, C. L. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ. Res. 102, 1008-1010 (2008). (Pubitemid 351667854)
87. Murry, C. E., Kay, M. A., Bartosek, T., Hauschka, S. D. & Schwartz, S. M. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J. Clin. Invest. 98, 2209-2217 (1996). (Pubitemid 26394193)
88. Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
89. Efe, J. A. et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nature Cell Biol. 13, 215-222 (2011).
90. Ratner, B. D. & Bryant, S. J. Biomaterials: where we have been and where we are going. Annu. Rev. Biomed. Eng. 6, 41-75 (2004). (Pubitemid 39209492)
91. Madden, L. R. et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl Acad. Sci. USA 107, 15211-15216 (2010).
92. Radisic, M. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl Acad. Sci. USA 101, 18129-18134 (2004). (Pubitemid 40054085)
93. Zimmermann, W. H. et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Med. 12, 452-458 (2006).
94. Reinecke, H., Zhang, M., Bartosek, T. & Murry, C. E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100, 193-202 (1999). (Pubitemid 29330019)
95. Stevens, K. R. et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc. Natl Acad. Sci. USA 106, 16568-16573 (2009).
96. Caspi, O. et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100, 263-272 (2007). (Pubitemid 46208727)
97. Dvir, T. et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl Acad. Sci. USA 106, 14990-14995 (2009).
98. Zakharova, L. et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc Res. 87, 40-49 (2010).
99. Brodsky, V. Y., Chernyaev, A. L. & Vasilyeva, I. A. Variability of the cardiomyocyte ploidy in normal human hearts. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 61, 289-294 (1991).
100. Rumyantsev, P. P., Erokhina, I. L., Antipanova, E. M. & Martynova, M. G. DNA and sex chromatin content in nuclei of conductive system and working myocytes of normal and hypertrophied human heart. Acta Histochem. Suppl. 39, 225-237 (1990).